Dulce Soler-Ferrán

Title: Dulce Soler-Ferrán: Innovator in Chemokine Modulation

Introduction

Dulce Soler-Ferrán is a prominent inventor based in Watertown, MA (US). She has made significant contributions to the field of biochemistry, particularly in the area of chemokine modulation. Her innovative work has led to the development of a patent that addresses important interactions within the immune system.

Latest Patents

Dulce Soler-Ferrán holds a patent titled "Method for identifying agents which modulate chemokine 'MEC'-induced functions of CCR3." This invention focuses on the interaction between MEC and the receptors CCR3 and CCR10. It involves agents such as ligands, antibodies, antagonists, agonists, inhibitors, and promoters that can alter this interaction. The patent outlines methods for detecting or identifying agents that can modulate the binding of MEC to these receptors. Additionally, it describes a method for treating subjects with inflammatory conditions by administering an effective amount of an agent that modulates this binding.

Career Highlights

Throughout her career, Dulce has demonstrated a strong commitment to advancing scientific knowledge and therapeutic applications. Her work has not only contributed to the understanding of chemokine interactions but also holds potential for developing new treatments for inflammatory diseases.

Collaborations

Dulce Soler-Ferrán has collaborated with notable colleagues, including Eric J Kunkel and Eugene C Butcher. These collaborations have further enriched her research and expanded the impact of her innovations in the field.

Conclusion

Dulce Soler-Ferrán is a trailblazer in the realm of chemokine research, with a patent that showcases her innovative approach to modulating immune responses. Her contributions are paving the way for new therapeutic strategies in treating inflammatory conditions.